Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keppra in alcohol dependence
NCT00325182Phase 4Completed
- Sponsor
- Boston University
- Start
- Jan 2006
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levetiracetam in alcohol dependence (2 arms), sponsored by Boston University. Primary endpoint: Change in mean number of drinks at 11 weeks. Started Jan 2006; status: completed.
02
Drugs
levetiracetam
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00325182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325182.